5 active warrant series; nearest expiry 2027-02-14.
Compare this book against every issuer →5 option grants covering 3,507,500 shares (~1.3% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.16 | Feb 14, 2027 150d | 50K | OTM | 0.0% | C$8K | Auto |
| option | $0.15 | Apr 15, 2027 210d | 100K | OTM | 0.0% | C$15K | Auto |
| option | $0.11 | Oct 7, 2027 385d | 88K | OTM | 0.0% | C$10K | Auto |
| option | $0.05 | Mar 14, 2028 544d | 500K | OTM | 0.2% | C$25K | Auto |
| option | $0.04 | Apr 14, 2028 575d | 2.8M | OTM | 1.0% | C$111K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
279,227,763 shares outstanding, plus 0 from warrants and 3,507,500 from options — a fully diluted 282,735,263 shares, or ~1.3% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
5 active warrant series; nearest expiry 2027-02-14.
Compare this book against every issuer →5 option grants covering 3,507,500 shares (~1.3% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.16 | Feb 14, 2027 150d | 50K | OTM | 0.0% | C$8K | Auto |
| option | $0.15 | Apr 15, 2027 210d | 100K | OTM | 0.0% | C$15K | Auto |
| option | $0.11 | Oct 7, 2027 385d | 88K | OTM | 0.0% | C$10K | Auto |
| option | $0.05 | Mar 14, 2028 544d | 500K | OTM | 0.2% | C$25K | Auto |
| option | $0.04 | Apr 14, 2028 575d | 2.8M | OTM | 1.0% | C$111K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
279,227,763 shares outstanding, plus 0 from warrants and 3,507,500 from options — a fully diluted 282,735,263 shares, or ~1.3% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
